Background Image
Previous Page  57 / 60 Next Page
Information
Show Menu
Previous Page 57 / 60 Next Page
Page Background

57

53. Tong GM, Rude RK. Magnesium

deficiency in critical illness. J Intensive Care

Med 2005;20:3-17.

54. Cholst IN, Steinberg SF, Tropper PJ, Fox

HE, Segre GV, Bilezikian JP. The influence of

hypermagnesemia on serum calcium and

parathyroid hormone levels in human subjects.

N Engl J Med 1984;310:1221-5.

55. Porter RH, Cox BG, Heaney D, Hostetter

TH, Stinebaugh BJ, Suki WN. Treatment of

hypoparathyroid patients with chlorthalidone.

N Engl J Med 1978;298:577-81.

56. Rubin MR, Sliney J Jr., McMahon DJ,

Silverberg SJ, Bilezikian JP. Therapy of

hypoparathyroidism with intact parathyroid

hormone. Osteoporos Int. [Clinical Trial

Research Support, N.I.H., Extramural Research

Support, Non-U.S. Gov't]. 2010;21:1927-34.

57. Winer KK, Sinaii N, Reynolds J, Peterson

D, Dowdy K, Cutler GB Jr. Long-term

treatment of 12 children with chronic

hypoparathyroidism: a randomized trial

comparing synthetic human parathyroid

hormone 1-34 versus calcitriol and calcium. J

Clin Endocrinol Metab 2010;95:2680-8.

58. Sikjaer T, Rejnmark L, Rolighed L,

Heickendorff L, Mosekilde L. The effect of

adding PTH(1-84) to conventional treatment of

hypoparathyroidism: a randomized, placebo-